Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Phase Distribution

Ph not_applicable

40%

Ph phase_2

20%

Ph phase_4

20%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 2Efficacy & side effects

1(25.0%)

Phase 4Post-market surveillance

1(25.0%)

N/ANon-phased studies

2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(4)

Terminated(1)

Detailed Status

Completed4

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 21 (25.0%)

Phase 41 (25.0%)

N/A2 (50.0%)

Trials by Status

withdrawn120%

completed480%

Recent Activity

0 active trials

Showing 5 of 5

withdrawnnot_applicable

Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

NCT02377492

completedphase_2

Clinical Trials (5)

Showing 5 of 5 trials

NCT02377492Not Applicable

Paracervical Vasopressin Injection Compared With Intramyometrial Vasopressin in Abdominal Myomectomy

Withdrawn

NCT03191240Phase 2

AMCPR (Augmented-Medication CardioPulmonary Resuscitation) Trial for OHCA

Completed

NCT04190004Not Applicable

Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia

Completed

NCT01687894

Vasopressin to Prevent Hypotension During Beach Chair Surgery

Completed

NCT02675868Phase 4

Effects of Vasopressors on Immune Response

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5